semaglutide cardiovascular outcomes news 2025 october Risks after GLP-1 Discontinuation New Science Suggests Semaglutide Improves

Why Melanotan II Is Not Approved Despite decades of research, Melanotan II has never received regulatory approval in any jurisdiction

Wegovy leads the field as a premier branded semaglutide injection, administered once weekly

:

You have a BMI that may qualify: Many prescription weight loss medications are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition

Using a large multicenter real-world dataset, we assessed clinical pregnancy, live birth, and time-to-event outcomes across body mass index subgroups to inform the reproductive safety profile of semaglutide and guide preconception counseling